476 results on '"Carlquist, John F."'
Search Results
2. The history and geographic distribution of a KCNQ1 atrial fibrillation risk allele
3. Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events
4. Abstract 16681: Ability of the Intermountain Risk Score Measured in 2019 (pre-COVID) to Predict Major Adverse Health Events in Patients Positive for SARS-CoV-2 in 2020
5. Abstract 14607: Randomized Controlled Trial of Once-Per-Week Intermittent Fasting for the Reduction of Low-Density Lipoprotein Cholesterol
6. Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System
7. Abstract 16041: Interaction of Genetic Variation at the ABO Locus With Short-Term Exposure to Elevated Fine Particulate Matter Air Pollution Results in Differential Associations With Acute Coronary Events
8. Impact of Selection Bias on Estimation of Subsequent Event Risk
9. Secretory Phospholipase A2-IIA and Cardiovascular Disease: A Mendelian Randomization Study
10. Validation and Quantification of Genetic Determinants of Lipoprotein-a Levels and Predictive Value for Angiographic Coronary Artery Disease
11. A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study
12. Relation of Routine, Periodic Fasting to Risk of Diabetes Mellitus, and Coronary Artery Disease in Patients Undergoing Coronary Angiography
13. Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort
14. Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population
15. The intermountain risk score predicts incremental age-specific long-term survival and life expectancy
16. A Polymorphism within a Conserved β₁-Adrenergic Receptor Motif Alters Cardiac Function and β-Blocker Response in Human Heart Failure
17. Abstract 11424: SARS-CoV-2 B.1.1.7 Variants Do Not Increase Risk of Subsequent Cardiovascular Disease
18. Abstract 10363: Mitochondrial DNA Copy Number is Associated with Severe Coronary Artery Disease and Risk of Subsequent Long-Term Major Adverse Cardiovascular Events
19. Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depression
20. Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population
21. Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease
22. Association of vitamin D levels with incident depression among a general cardiovascular population
23. Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial
24. Cytomegalovirus Induction of Interleukin-6 in Lung Fibroblasts Occurs Independently of Active Infection and Involves a G Protein and the Transcription Factor, NF-κB
25. Depression After Coronary Artery Disease Is Associated With Heart Failure
26. Superior predictive ability for death of a basic metabolic profile risk score
27. Genotype-Based Dosing Algorithms for Warfarin Therapy: Data Review and Recommendations
28. Usefulness of Routine Periodic Fasting to Lower Risk of Coronary Artery Disease in Patients Undergoing Coronary Angiography
29. Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility
30. An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction
31. Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing
32. A Prognostic Tool for COVID-19 Decision Support: The Intermountain Risk Score Predicts Major Adverse Health Events in Patients Positive for COVID-19
33. Progress in unraveling the genetics of coronary artery disease and myocardial infarction
34. Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study
35. Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association study
36. Multiple Less Common Genetic Variants Explain the Association of the Cholesteryl Ester Transfer Protein Gene With Coronary Artery Disease
37. Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?
38. Usefulness of a Complete Blood Count-Derived Risk Score to Predict Incident Mortality in Patients With Suspected Cardiovascular Disease
39. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease
40. A polymorphism within a conserved [[beta].sub.1]-adrenergic receptor motif alters cardiac function and [beta]-blocker response in human heart failure
41. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease
42. Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes
43. The cholesteryl eser transfer protein Taq 1 B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease
44. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention
45. Relation of Serum Total Cholesterol, C-Reactive Protein Levels, and Statin Therapy to Survival in Heart Failure
46. Lipoprotein-associated phospholipase A 2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death
47. Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention
48. Genotype-Based Dosing Algorithms for Warfarin Therapy:Data Review and Recommendations
49. Abstract 271: Mitochondrial DNA Copy Number in Peripheral Blood Cells is Associated With All -Cause Mortality in Older Cardiovascular Patients
50. The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.